Skip to main content
Caplight Logo









Magstim

Magstim

Private
WhitlandHealthcare & Life Scienceshttps://magstim.com

Last Round

Buyout/LBO

Sep 1, 2015

Company Overview

Magstim operates in Healthcare & Life Sciences and is based in Whitland. It was founded in 1990.

Magstim is a medical device company that develops and manufactures neurotechnology solutions, including Transcranial Magnetic Stimulation (TMS) and Electroencephalography (EEG) systems, for clinical and research applications.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Mental Health, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Magstim Comparables

Compare Magstim with similar companies based on industry and business-model similarity.

Magstim comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MagVenture
92%
BrainsWay Ltd.
84%
Nexstim Oyj
84%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Magstim Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Buyout/LBOSep 1, 2015
Buyout/LBOMar 30, 2013
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Magstim Investors

Notable investors and investment history

Magstim investors
InvestorRounds
Telegraph Hill PartnersBuyout/LBO
Development Bank of WalesBuyout/LBO

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 22, 2026

    Monthly visitors increased 57% MoM.

  • Jul 1, 2025

    Monthly visitors increased 43% MoM, reaching 6.3K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Magstim Filings

Explore SEC and related filing metadata, where available.

Magstim filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Magstim's valuation, stock price, and market status.

Is Magstim a public or private company?

Magstim is a private company.

What is the current stock price of Magstim?

Magstim is a private company, so its shares have no public market price. Caplight tracks Magstim's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Magstim worth (valuation)?

Valuation information for Magstim is not publicly available.

Can I buy Magstim stock?

Magstim shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Magstim's last funding round?

Magstim's most recent funding round was Buyout/LBO on September 1, 2015.

Who are the main investors in Magstim?

Key investors in Magstim include Telegraph Hill Partners, Development Bank of Wales.

Will Magstim IPO soon?

No public IPO plans have been announced for Magstim.

How can I track Magstim secondary market activity?

Caplight tracks bids, offers, and trades in Magstim's shares on secondary markets.

Firmographic Details

HeadquartersWhitland
Employee Range97
Year Founded1990
Last FundingSep 1, 2015

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?